Reagent Kit for Simultaneous Detection of HCV RNA, HBV DNA, and HIV RNA in Clinical Samples by PCR with Hybridization-Fluorescent Detection

Reagent Kit for Simultaneous Detection of HCV RNA, HBV DNA, and HIV RNA in Clinical Samples by PCR with Hybridization-Fluorescent Detection

This reagent kit is intended for the simultaneous detection of Hepatitis C virus (HCV) RNA, Hepatitis B virus (HBV) DNA, and Human Immunodeficiency Virus (HIV) RNA in clinical specimens using polymerase chain reaction (PCR) with hybridization-fluorescent detection, according to TU 9398-069-01897593-2012, FRT format.

Configuration Options:

• Form 1: Includes the QIAsymphony Virus/Bacteria Midi Kit for nucleic acid extraction on the QIAsymphony SP automated workstation (Qiagen, Germany) and PCR Kit FRT-A variant, adapted for the QIAsymphony AS automated reaction preparation module (Qiagen, Germany).
• Form 3: Includes MAGNO-sorb Kit variant 100-1000 and PCR Kit FRT variant.
• Form 4: Includes PCR Kit FRT-A variant, adapted for the QIAsymphony AS automated reaction preparation module (Qiagen, Germany).
• Form 5: Includes PCR Kit FRT variant.
• Form 6: Includes PCR Kit FRT-4x variant.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Simultaneous Detection of HCV RNA, HBV DNA, and HIV RNA in Clinical Samples by PCR with Hybridization-Fluorescent Detection, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.